Cardiovascular disease in patients with Type 2 diabetes mellitus: ambulatory therapeutist’s role in improving the quality of pharmaceutical prevention and treatment

As a part of a randomized clinical trial, the potential of patients’ education and monitoring by ambulatory therapeutists for improving pharmaceutical prevention and treatment effectiveness in Type 2 diabetes mellitus (DM-2) was evaluated. After 12 months, patients’ compliance and lipid level contro...

Full description

Bibliographic Details
Main Author: E. A. Palferova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2008-02-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1528
_version_ 1797857214580391936
author E. A. Palferova
author_facet E. A. Palferova
author_sort E. A. Palferova
collection DOAJ
description As a part of a randomized clinical trial, the potential of patients’ education and monitoring by ambulatory therapeutists for improving pharmaceutical prevention and treatment effectiveness in Type 2 diabetes mellitus (DM-2) was evaluated. After 12 months, patients’ compliance and lipid level control improved significantly, as well as selfrated health and quality of life.
first_indexed 2024-04-09T20:53:07Z
format Article
id doaj.art-52c5afc183544e6f82d701a8c29a49f6
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2024-04-09T20:53:07Z
publishDate 2008-02-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-52c5afc183544e6f82d701a8c29a49f62023-03-29T21:23:15Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202008-02-010157601313Cardiovascular disease in patients with Type 2 diabetes mellitus: ambulatory therapeutist’s role in improving the quality of pharmaceutical prevention and treatmentE. A. Palferova0Бутурлиновская ЦРБ Воронежской области; Российская медицинская академия последипломного образования РосздраваAs a part of a randomized clinical trial, the potential of patients’ education and monitoring by ambulatory therapeutists for improving pharmaceutical prevention and treatment effectiveness in Type 2 diabetes mellitus (DM-2) was evaluated. After 12 months, patients’ compliance and lipid level control improved significantly, as well as selfrated health and quality of life.https://russjcardiol.elpub.ru/jour/article/view/1528type 2 diabetes mellituscardiovascular diseasepreventiontreatmenttherapeutistambulatory clinic
spellingShingle E. A. Palferova
Cardiovascular disease in patients with Type 2 diabetes mellitus: ambulatory therapeutist’s role in improving the quality of pharmaceutical prevention and treatment
Российский кардиологический журнал
type 2 diabetes mellitus
cardiovascular disease
prevention
treatment
therapeutist
ambulatory clinic
title Cardiovascular disease in patients with Type 2 diabetes mellitus: ambulatory therapeutist’s role in improving the quality of pharmaceutical prevention and treatment
title_full Cardiovascular disease in patients with Type 2 diabetes mellitus: ambulatory therapeutist’s role in improving the quality of pharmaceutical prevention and treatment
title_fullStr Cardiovascular disease in patients with Type 2 diabetes mellitus: ambulatory therapeutist’s role in improving the quality of pharmaceutical prevention and treatment
title_full_unstemmed Cardiovascular disease in patients with Type 2 diabetes mellitus: ambulatory therapeutist’s role in improving the quality of pharmaceutical prevention and treatment
title_short Cardiovascular disease in patients with Type 2 diabetes mellitus: ambulatory therapeutist’s role in improving the quality of pharmaceutical prevention and treatment
title_sort cardiovascular disease in patients with type 2 diabetes mellitus ambulatory therapeutist s role in improving the quality of pharmaceutical prevention and treatment
topic type 2 diabetes mellitus
cardiovascular disease
prevention
treatment
therapeutist
ambulatory clinic
url https://russjcardiol.elpub.ru/jour/article/view/1528
work_keys_str_mv AT eapalferova cardiovasculardiseaseinpatientswithtype2diabetesmellitusambulatorytherapeutistsroleinimprovingthequalityofpharmaceuticalpreventionandtreatment